<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02427906</url>
  </required_header>
  <id_info>
    <org_study_id>2014-151</org_study_id>
    <secondary_id>WCH-2014-151</secondary_id>
    <nct_id>NCT02427906</nct_id>
  </id_info>
  <brief_title>Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic Patients</brief_title>
  <official_title>Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota and Associated Inflammatory Factors in Cirrhotic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West China Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of transjugular intrahepatic
      portosystemic shunt on gut microbiota and associated inflammatory factors in cirrhotic
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cirrhosis is associated with qualitative and quantitative changes in the gut microbiota that
      can potentiate disease progression and complications such as hepatic encephalopathy (HE) and
      infections. Dysbiosis or altered gut microbiota, due to decreased autochthonous or commensal
      taxa, has been found in stool and colonic mucosa in cirrhotic patients, which is in turn
      linked with disease severity and systemic inflammation.

      TIPS can decompress the hypertensive portal vein,so that the intestinal congestion can be
      decrease too. Hence we summarize that TIPS may have effect on gut microbiota and associated
      inflammatory factors in cirrhotic patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Changes in fecal microbiota</measure>
    <time_frame>baseline and 6 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of hepatic encephalopathy</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of blood inflammatory parameter including IL-2（interleukin 2）,IL-6,IL-10,IL-8，TNF-α</measure>
    <time_frame>baseline and 6 month</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Acquired Portal-systemic Shunt Due to Cirrhosis</condition>
  <condition>Hepatic Encephalopathy</condition>
  <arm_group>
    <arm_group_label>TIPS group</arm_group_label>
    <description>patients who have transjugular intrahepatic portosystemic shunt</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-TIPS group</arm_group_label>
    <description>patients who have endoscopic variceal ligation</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum，stool
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt for any
        indication at West China Hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cirrhotic patients who received TIPS;

          -  Treatment-naive to TIPS and major operation involving liver such as surgical shunt,
             hepatic resection and liver transplantation)

        Exclusion Criteria:

          -  Uncontrolled infection or sepsis;

          -  Hepatobiliary or pancreatic malignancy or biliary obstruction;

          -  Vital organ dysfunction;

          -  Administration of antibiotics (after TIPS and 2 weeks before TIPS);

          -  Cachexia;

          -  Pregnant or breeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhu Wang, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>West China Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhu Wang, PhD</last_name>
    <phone>18981745741</phone>
    <email>1988wangzhu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mingshan Jiang, MD</last_name>
    <phone>15680951783</phone>
    <email>jmsalice333@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>West China Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhu Wang, PhD</last_name>
      <phone>18981745741</phone>
      <email>1988wangzhu@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2015</study_first_submitted>
  <study_first_submitted_qc>April 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2015</study_first_posted>
  <last_update_submitted>October 26, 2015</last_update_submitted>
  <last_update_submitted_qc>October 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West China Hospital</investigator_affiliation>
    <investigator_full_name>Wang Zhu, MD</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>cirrhosis</keyword>
  <keyword>gut microbiota</keyword>
  <keyword>transjugular portosystemic shunt</keyword>
  <keyword>hepatic encephalopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Hepatic Encephalopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

